Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults.
In June 2021, the ACR released an updated guideline for the treatment of rheumatoid arthritis.1 The guideline underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. It also includes new recommendations for specific high-risk groups. Learn more in our article.
FEATURED ARTICLE: ACR Study Summary: Rehabilitation Dose in Adults with RA